75A50322F80030↗
Chartwell RX LLC received this contract from Aspr/Orm-Sns, Office of Assistant Secretary for Preparedness and Response: -$40.63M obligated so far for drugs and biologicals. Its period of performance ended 2026-03-23.
Key facts · data as of Oct 26, 2026
- Recipient
- Chartwell RX LLC
- Awarding agency
- Office of Assistant Secretary for Preparedness and Response (Department of Health and Human Services)
- Contracting office
- Aspr/Orm-Sns (75A503)
- Obligated to date
- -$40.63M
- Potential value
- $99.05M
- Ends
- 2026-03-23
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.
Cite this page: SpendQuery, Award 75A50322F80030, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75A50322F80030_7505_36F79720D0198_3600
Chartwell RX LLC: all federal awards · Department of Health and Human Services: spending · Aspr/Orm-Sns: what it buys
DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES
What it is
- Product or service
- Drugs and Biologicals (PSC 6505)
- Industry
- Pharmaceutical Preparation Manufacturing (NAICS 325412)
- Contracting office
- Aspr/Orm-Sns (75A503)
- Competition
- Full and open competition · 2 offers received
- Set-aside
- Small business
- Pricing
- Firm fixed price
- How it was bought
- GSA Schedule · under 36F79720D0198
- Solicitation
- 75A50122Q00018
- Where the work is
- Rockland, NY · district NY-17
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
7 actions since 2022-11-08. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2026-03-24 | P00007 | Supplemental agreement (work within scope) | -$40.63M | THE PURPOSE OF THIS MODIFICATION IS TO DESCOPE AMOXICILLIN TRIHYDRATE 500 MG CLINS. |
| 2026-02-20 | P00006 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND AMOXICILLIN TRIHYDRATE 500 MG CLINS |
| 2026-01-30 | P00005 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS TO EXTEND AMOXICILLIN TRIHYDRATE 500 MG CLINS |
| 2025-12-29 | P00004 | Supplemental agreement (work within scope) | $0 | THE PURPOSE OF THIS MODIFICATION IS FOR AMOXICILLIN TRIHYDRATE 500 MG CLINS |
| 2025-06-27 | P00003 | Change order | $0 | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE. |
| 2024-09-24 | P00002 | Administrative change | $0 | THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE A NO COST EXTENSION TO EXTEND THE PERIOD OF PERFORMANCE. |
| 2022-11-08 | P00001 | Administrative change | $0 | DOXYCYCLINE HYCLATE TABLETS AND AMOXICILLIN TRIHYDRATE CAPSULES |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗